Acute haemodynamic effects of ajmaline and prajmaline in patients with coronary heart disease
Thirty patients undergoing cardiac catheterisation for coronary artery disease received parenteral ajmaline (15 patients) or prajmaline (15 patients). There were no statistically significant induced changes in left ventricular systolic or end diastolic pressures, indirect left atrial pressure, pulmonary artery mean pressure, cardiac output or left ventricular ejection fraction compared to control values. Intravenous prajmaline bitartrate in 15 patients with angina did not significantly alter work capacity, maximum exercise heart rate or systolic blood pressure compared to control values. Five patients developed transient minor conduction defects (2 LBBB, 1 RBBB, 2 prolonged PR interval): all five were also receiving long-term treatment with beta blockers and nifedipine.
Key wordsajmaline prajmaline acute haemodynamic effects coronary heart disease
Unable to display preview. Download preview PDF.
- 1.Obayashi K, Nagasawa K, Mandel WJ, Vyden JK, Parmley WW (1976) Cardiovascular effects of ajamline. Am Heart J 92: 487–496Google Scholar
- 2.Bussmann WD, Muller E, Hanel HJ, Kaltenbach M (1978) Orally administered prajmalium bitartrate in acute and chronic ventricular arrhythmias. Am J Cardiol 41: 577–583Google Scholar
- 3.Wellens HJJ, Durrer D (1974) Effort of procaineamide, quinidine and ajmaline in the Wolff-Parkinson-White syndrome. Circulation 50: 114–120Google Scholar
- 4.Opie LH (1980) Anti-arrhythmic drugs. Drugs and the heart. Published by LancetGoogle Scholar
- 5.Sandler H, Dodge HT (1968) The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 75: 325–334Google Scholar
- 6.Burkart F, Barold S, Sowton E (1967) Haemodynamic effects of repeated exercise. Am J Cardiol 20: 509–515Google Scholar
- 7.Klein WW, Pavek P, Brandt D (1979) Information on neo-gilurytmal. Published by Guilini Pharma GmbH, Hannover, FRG, pp 21–33Google Scholar